Patents by Inventor William J Addicks

William J Addicks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenytoin sodium pharmaceutical compositions
    Patent number: 6620432
    Abstract: A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The erodible matrix comprises binder(s) and diluent(s) which control the release of drug from the pharmaceutical composition. The erodible matrix can further comprise an alkaline pH modifier.
    Type: Grant
    Filed: May 11, 2001
    Date of Patent: September 16, 2003
    Assignee: Mylan Pharmaceuticals Inc.
    Inventors: William J. Addicks, Joseph P. Duda, Daniel A. Snider, Kerry R. Benson
  • Phenytoin sodium pharmaceutical compositions
    Publication number: 20010043945
    Abstract: A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The erodible matrix comprises binder(s) and diluent(s) which control the release of drug from the pharmaceutical composition. The erodible matrix can further comprise an alkaline pH modifier.
    Type: Application
    Filed: May 11, 2001
    Publication date: November 22, 2001
    Applicant: MYLAN PHARMACEUTICALS INC.
    Inventors: William J. Addicks, Joseph P. Duda, Daniel A. Snider, Kerry R. Benson
  • Phenytoin sodium pharmaceutical compositions
    Patent number: 6274168
    Abstract: A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The erodible matrix comprises binder(s) and diluent(s) which control the release of drug from the pharmaceutical composition. The erodible matrix can further comprise an alkaline pH modifier.
    Type: Grant
    Filed: February 23, 1999
    Date of Patent: August 14, 2001
    Assignee: Mylan Pharmaceuticals Inc.
    Inventors: William J Addicks, Joseph P Duda, Daniel A. Snider, Kerry R Benson
  • Oral anticoagulant/platelet inhibitor low dose formulation
    Patent number: 5041430
    Abstract: There are disclosed combination products useful for the treatment and/or prevention of a first or recurrent myocardial infarction or a first or recurrent stroke. Said combination products comprise low doses of an oral anticoagulant, preferably warfarin and platelet inhibiting agents, including non-steroidal antiinflammatory agents and preferrably aspirin.
    Type: Grant
    Filed: September 18, 1989
    Date of Patent: August 20, 1991
    Assignee: Du Pont Mereck Pharmaceutical Company
    Inventors: William J. Addicks, Joseph A. Mollica, Gary H. Slatko